[{"会社名":"大正製薬ホールディングス(株)【4581】","証券コード":"4581","　":"前期","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"295,957百万円","営業利益":"41,683百万円","経常利益":"51,244百万円","当期利益":"32,692百万円","EPS（一株当たり利益）":"403.18円","調整一株当たり利益":"403.07円","BPS（一株当たり純資産）":"7,401.61円","総資産":"728,442百万円","自己資本":"600,083百万円","資本金":"30,000百万円","有利子負債":"---","自己資本比率":"82.4%","ROA（総資産利益率）":"4.65%","ROE（自己資本利益率）":"5.61%","総資産経常利益率":"7.30%"},{"会社名":"大正製薬ホールディングス(株)【4581】","証券コード":"4581","　":"2期前","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月10日","決算月数":"12か月","売上高":"285,168百万円","営業利益":"35,337百万円","経常利益":"44,173百万円","当期利益":"26,320百万円","EPS（一株当たり利益）":"325.26円","調整一株当たり利益":"325.22円","BPS（一株当たり純資産）":"6,975.94円","総資産":"676,388百万円","自己資本":"565,715百万円","資本金":"30,000百万円","有利子負債":"---","自己資本比率":"83.6%","ROA（総資産利益率）":"4.03%","ROE（自己資本利益率）":"4.82%","総資産経常利益率":"6.77%"},{"会社名":"大正製薬ホールディングス(株)【4581】","証券コード":"4581","　":"3期前","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月11日","決算月数":"12か月","売上高":"271,230百万円","営業利益":"38,412百万円","経常利益":"46,201百万円","当期利益":"24,357百万円","EPS（一株当たり利益）":"296.20円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"6,560.67円","総資産":"629,506百万円","自己資本":"527,377百万円","資本金":"30,000百万円","有利子負債":"---","自己資本比率":"83.8%","ROA（総資産利益率）":"3.87%","ROE（自己資本利益率）":"4.62%","総資産経常利益率":"7.34%"}]